On the morning of September 21, major A-share indices rose across the board, with the pharmaceutical and biotech sector showing strength. Huaren Pharmaceutical surged in a straight line during trading and sealed a 20cm limit up within 3 minutes. By the midday close, the Shanghai Composite Index stood at 3,933.37 points, up 0.55%, the Shenzhen Component Index rose 0.57%, the ChiNext Index gained 0.93%, and the STAR Composite Index added 0.40%. Combined turnover across Shanghai, Shenzhen and Beijing reached 1.339 trillion yuan in the half-day session. On the news front, on September 18, the Ministry of Industry and Information Technology, the National Development and Reform Commission and eight other departments jointly issued the 15th Five-Year Plan for the development of the pharmaceutical industry, explicitly proposing that during the 15th Five-Year Plan period, operating revenue of pharmaceutical industrial enterprises above designated size should exceed 3.5 trillion yuan, and the innovation drug industry should achieve an average annual growth rate of over 20%. The memory chip concept was also active. Changxin Technology announced on the evening of September 20 that its fifth-generation process technology platform had officially entered mass production, and simultaneously showcased a high-capacity LPDDR5X product built on that platform. This marks the first time a domestic 10,667 Mbps high-speed LPDDR5X memory chip has achieved mass production and application.
Huaren Pharmaceutical Co LtdHuaren Pharmaceutical hit 20cm limit up as the pharma sector rallied after eight ministries issued the 15th Five-Year Plan targeting over 3.5 trillion yuan in pharma revenue and 20%+ annual innovative-drug growth.
CXMT CorporationChangXin Technology announced its fifth-generation process platform entered mass production and showcased a domestically first 10,667 Mbps LPDDR5X memory chip.
